These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11165970)

  • 21. Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome.
    Lavie L; Lotan R; Hochberg I; Herer P; Lavie P; Levy AP
    Sleep; 2003 Aug; 26(5):592-5. PubMed ID: 12938813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Coronary restenosis 6 months following transluminal atherectomy].
    Kaufmann U; Garratt KN; Vlietstra RE; Holmes DR
    Schweiz Med Wochenschr; 1990 Nov; 120(45):1694-6. PubMed ID: 2251487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restenosis and gene polymorphisms. All humans are equal, but some humans are more equal than others.
    Caixeta A; Weisz G
    Cardiology; 2009; 112(4):260-2. PubMed ID: 18758182
    [No Abstract]   [Full Text] [Related]  

  • 25. Usefulness of dobutamine echocardiography for detecting restenosis after percutaneous transluminal coronary angioplasty.
    Heinle SK; Lieberman EB; Ancukiewicz M; Waugh RA; Bashore TM; Kisslo J
    Am J Cardiol; 1993 Dec; 72(17):1220-5. PubMed ID: 8256695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of exercise electrocardiography in the detection of restenosis after coronary angioplasty in patients with one-vessel disease.
    Malekianpour M; Rodés J; Côté G; Juneau M; Bonan R; Lespérance J; Couturier A; Tardif JC
    Am J Cardiol; 1999 Aug; 84(3):258-63. PubMed ID: 10496432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis.
    Blum A; Giladi M; Weinberg M; Kaplan G; Pasternack H; Laniado S; Miller H
    Am J Cardiol; 1998 Apr; 81(7):866-8. PubMed ID: 9555776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between HLA-C locus and restenosis after coronary artery balloon angioplasty.
    Watanabe Y; Yamada N; Yokoi H; Fujiwara Y; Mokuno H; Daida H; Yamaguchi H
    JAMA; 1997 Mar; 277(12):983-4. PubMed ID: 9091671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haptoglobin polymorphism in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and near-infrared spectroscopy in patients with coronary artery disease.
    Buljubasic N; Oemrawsingh RM; Smeets MB; Cheng JM; Regar E; van Geuns RJ; Serruys PW; Boersma E; Akkerhuis KM; Kardys I; Arslan F
    Int J Cardiol; 2016 Oct; 221():682-7. PubMed ID: 27423090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of C-reactive protein on in-stent restenosis: a meta-analysis.
    Li JJ; Ren Y; Chen KJ; Yeung AC; Xu B; Ruan XM; Yang YJ; Chen JL; Gao RL
    Tex Heart Inst J; 2010; 37(1):49-57. PubMed ID: 20200627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised trial of elective stenting after successful percutaneous transluminal coronary angioplasty of occluded coronary arteries.
    Hancock J; Thomas MR; Holmberg S; Wainwright RJ; Jewitt DE
    Heart; 1998 Jan; 79(1):18-23. PubMed ID: 9505913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of haematological parameters before coronary angioplasty on subsequent restenosis.
    Avci A; Boyaci A; Cağli K; Cosgun A; Gokce V; Duru E; Korkmaz S
    Acta Cardiol; 2004 Jun; 59(3):263-8. PubMed ID: 15255457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.
    Levy AP; Friedenberg P; Lotan R; Ouyang P; Tripputi M; Higginson L; Cobb FR; Tardif JC; Bittner V; Howard BV
    Diabetes Care; 2004 Apr; 27(4):925-30. PubMed ID: 15047650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of predictive factors associated with recurrent restenosis after second percutaneous transluminal coronary angioplasty].
    Kishi K; Hiasa Y; Tanaka H; Kinoshita M; Tanimoto M; Wada T; Aihara T
    J Cardiol; 1997 Jan; 29(1):7-12. PubMed ID: 9023674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty.
    Macdonald RG; Panush RS; Pepine CJ
    Am J Cardiol; 1987 Jul; 60(3):56B-60B. PubMed ID: 2956845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
    Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
    Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis.
    Vitalis Z; Altorjay I; Tornai I; Palatka K; Kacska S; Palyu E; Tornai D; Udvardy M; Harsfalvi J; Dinya T; Veres G; Lakatos PL; Papp M
    Hum Immunol; 2011 Apr; 72(4):348-54. PubMed ID: 21262313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis.
    Purushothaman KR; Purushothaman M; Levy AP; Lento PA; Evrard S; Kovacic JC; Briley-Saebo KC; Tsimikas S; Witztum JL; Krishnan P; Kini A; Fayad ZA; Fuster V; Sharma SK; Moreno PR
    J Am Coll Cardiol; 2012 Jul; 60(2):112-9. PubMed ID: 22766337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Restenosis after transluminal coronary angioplasty. Clinical and therapeutic aspects].
    Metzger JP; Tabone X; Le Feuvre C; Bénichou JM; Hajri S; Heulin A; Vacheron A
    Ann Med Interne (Paris); 1990; 141(4):325-8. PubMed ID: 2240944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.